On the Couch with Dr Andreas Fouras (4DX): Lung Imaging, CTPA and the Billion-Dollar Opportunity
About this episode
Henry Jennings speaks with Dr Andreas Fouras about lung imaging technology and its market potential.
In this episode of On the Couch, Henry Jennings speaks with Dr Andreas Fouras, Managing Director and CEO of 4DMedical (ASX: 4DX). Many Marcus Today members will know 4DX from when it was a fraction of its current price. Henry has long been a fan of the company, which has developed XV Technology – a proprietary software platform enabling non-invasive, quantitative imaging and analysis of lung function. They cover the opportunity in replacing CTPA scans, the Pro Medicus relationship, and what t...
More episodes of On the Couch
- On the Couch with Igor Pejic: New Rules for Investing in the Tech Age
- On the Couch with Jonathon Higgins (UCP): Neoclouds, Electrification and the ASX Opportunity
Explore listener stats, chart rankings, contacts and more on the On the Couch podcast page.